HWN Suggests

Malaria: Targets and Drugs for All Stages

Unfortunately, resistance frequently arises to any widely-used single drug. In the last five years, strong gains were made through combinations such as artemisinin-combination therapies (ACTs) where artemisinins were combined with a partner to which resistance had emerged. But now there are signs of resistance to artemisinins, the spread of which would wipe out recent gains. However in HIV, three drug combinations and first, second and third line combinations are being used to win the fight against AIDS. Malaria has proved a challenge, but there is hope; compared to viruses, the parasites’ mutation rate is lower and disease management is relatively straightforward. Thus expanding the existing…

read full article

Featured

  Health Pharma First New Malaria Drug in Years Performs Strongly in Late-Stage Testing

Novartis said its experimental treatment cured more than 99% of malaria cases in the trial, marking a big step toward approval.

  History of antimalarials drugs

MMV is developing next-generation medicines to address drug resistance and improve compliance.

 Are Fake Drugs The Reason Malaria Sickens Millions a Year?

Fraudulent, expired and low-quality medicines contribute to the disease’s death toll—and could worsen drug resistance.

 Combination Therapy Strategies for the Treatment of Malaria

Malaria is a vector- and blood-borne infection that is responsible for a large number of deaths around the world. Most of the currently used antimalarial therapeutics suffer from drug resistance. The other limitations associated with the currently used antimalarial drugs are poor drug bioavailability, drug toxicity, and poor water solubility. Combination therapy is one of the best approaches that is currently used to treat malaria, whereby two or more therapeutic agents are combined. Different combination therapy strategies are used to overcome the aforementioned limitations.

 New malaria drug could be a life-saver as the standard drug shows signs of weakness

GanLum stands for ganaplacide/lumefantrine, a combination of two drugs, one new and one old (most antimalarial treatments are combinations of drugs, to target the parasite at different stages of infection). The new one, ganaplacide, was discovered by scientists at Novartis after screening over 2.3 million molecules for antimalarial properties. It seems to work by disrupting the malaria parasites' ability to live inside human red blood cells.

 To fight malaria, scientists want to poison mosquitoes—with human blood

Low doses of a drug already approved for treating rare genetic conditions in humans kills mosquitoes dead. Scientists say it could be a valuable new tool in the fight against disease.

Articles of Interest

Chemoprophylaxis and Treatment

Several classes of antimalarial drugs are available. Drugs that eliminate developing or dormant liver forms are called tissue schizonticides; those that act on erythrocytic parasites are blood schizonticides; and those that kill sexual stages and prevent transmission to mosquitoes are gametocides. No single available agent can reliably effect a radical cure, ie, eliminate both hepatic and erythrocytic stages. Few available agents are causal prophylactic drugs, ie, capable of preventing erythrocytic infection. However, all effective chemoprophylactic agents kill erythrocytic parasites before they increase sufficiently in number to cause clinical disease.

Dosing Recommendations for Prevention and Treatment of Malaria

For Travel to Chloroquine-Resistant Areas: Atovaquone/proguanil once daily started 1–2 days before travel, for duration of stay, and then for 1 week after returning home.

An ancient foe and a modern arms race

Our immune systems mount responses to kill or supress invading bacteria, viruses or parasites. Over time, the pathogens develop ways to evade our responses. We are often aided by drugs or vaccines, though these too may be overcome, and the cycle continues. Malaria, a disease that has been with humans for over 50,000 years, is no different.

Antimalaria drug resistance: an endless run

Artemisinin is now the first line of treatment. This compound is derived from a plant (artemisia annua) and granted its discoverer (Professor Tu Youyou) the Nobel prize in Medicine in 2015. This drug is often used in combination with other drugs (i.e. artesunate, sulfadoxine) as it is rapidly cleared by the body and thus can kill the parasites at a fast pace before another long-lasting drug ends the process. These combinations are known as Artemisinin-based Combination Therapies (ACT). So far, five of them are in use. This form of drug is preferred to the use of Artemisinin alone to avoid the development of resistance.

Are anti-malaria drugs set to be a game-changer in the battle against COVID-19?

Based on preliminary laboratory evidence and small scale trials on humans who are symptomatic, there is some promise that chloroquine and hydroxychloroquine can treat COVID-19. But there is no published literature yet other than some evidence that in the test tube these compounds can interfere with the way a virus attaches to cells.

Are antimalarial drugs still effective?

Studies reveal emerging resistance to first–line treatments

Artemisia against malaria: efficient but banished.

The large family of Artemisia plants have been used as herbal medicine for millenniums in all regions of the world. Artemisia annua came under the spotlight during the Vietnam War. Viêt-Cong who operated in swamps and rain forests lost more soldiers by mosquito bites than by American bullets. As a last resort they spoke to their Chinese older brother and Mao Tse Tong, in spite of the traditions, instructed some scientists to see if there was some hidden information kept in archives. And actually, wild Artemisia has been used for millenniums in several regions of China and is still used to treat fevers and malaria. It was easy to acquire tons of this dried herb for Viêt-Cong. Taken as an infusion it worked wonders. The Americans, faithful to their less efficient pills, never knew what was going on.

Artemisinin resistance and malaria elimination: Where are we now?

The emergence of artemisinin resistance is a major obstacle to the global malaria eradication/elimination programs. Artemisinin is a very fast-acting antimalarial drug and is the most important drug in the treatment of severe and uncomplicated malaria. For the treatment of acute uncomplicated falciparum malaria, artemisinin derivatives are combined with long half-life partner drugs and widely used as artemisinin-based combination therapies

Artemisinins: their growing importance in medicine

Artemisinins are derived from extracts of sweet wormwood (Artemisia annua) and are well established for the treatment of malaria, including highly drug-resistant strains. Their efficacy also extends to phylogenetically unrelated parasitic infections such as schistosomiasis.

At Long Last, Can Malaria Be Eradicated?

Two new vaccines may finally turn back an ancient plague. But in unexpected ways, their arrival also complicates the path to ending the disease.

Blue Dye Kills Malaria Parasites — But There Is One Catch

It's hard to imagine that a blue dye sold in pet food stores in the U.S. to fight fungal infections in tropical fish could be a potent weapon against malaria.

Can We Beat Drug-Resistant Malaria At Its Birthplace?

Artemisinin used to clear P. falciparum in a day; now, it can take several. The parasite has started to become resistant. The wonder drug is failing. It is the latest reprise of a decades-long theme: we attack malaria with a new drug, it mounts an evolutionary riposte.

Drug-resistant malaria is emerging in Africa. Doctors are worried — yet hopeful

So far, the ACTs still work. But in an experimental setting, as drug resistance sets in, it can lengthen treatment by three or four days. That may not sound like much, said Timothy Wells, chief scientific officer of the nonprofit Medicines for Malaria Venture. But "the more days of therapy you need," he says, "then the more there is the risk that people don't finish their course of therapy."

End of the road for Lariam? The malaria drug soldiers claim increases psychosis

The main challenge with preventing malaria is that some species of mosquito in certain countries have become resistant to the commonly used drugs such as chloroqine and proguanil. Lariam was developed to overcome such resistance and so was deemed to be useful if travelling to countries where there is a type of malaria that is particularly difficult to treat. But no single medicine is effective against all malaria parasites. The choice of a particular medicine depends on the sensitivity of the malaria parasites found in particular areas. But Lariam became increasingly controversial.

Evolution of artemisinin-resistant malaria

Despite huge efforts to treat and eradicate the disease, in 2015, more than 200 million people were infected with malaria. Nearly half a million people died. The current frontline treatment for malaria is a drug called artemisinin but treatment is complicated by the fact that the malaria-causing parasite Plasmodium falciparum is exceptionally good at developing resistance to antimalarial drugs.

Experience: my anti-malaria drugs made me psychotic

Looking back, I can see the effects started before I left for Ghana, but at the time I blamed it on the stress of the trip ahead. My mind became chaotic, and I couldn’t make any decisions. I tried to pack, but would take something in each hand and stare at them in confusion. In the end, I had to ask my mum to help.

Experience: my anti-malaria drugs made me psychotic

Istarted taking the anti-malarial drug Lariam before going to Ghana in October 2013. I was 20 years old, living near Rotterdam and studying healthcare technology – the trip was part of my degree. The nurse asked me if I or anyone in my family had ever had psychological problems, which I hadn’t. She warned me that some people experience side-effects, including hallucinations. I pocketed my prescription and set a reminder on my phone to take one pill a week.

Herbs And Empires: A Brief History Of Malaria Drugs

What do Jesuit priests, gin and tonics, and ancient Chinese scrolls have in common? They all show up in our animated history of malaria. It's a story of geopolitical struggles, traditional medicine, and above all, a war of escalation between scientists and a tiny parasite. Malaria has proved to be a wily foe: Every time we think we have it backed into a corner, it somehow escapes.

Malaria medication: your questions answered

The female Anopheles mosquito bites from dusk to dawn and does not hum or leave a welt at the site of the bite, so you won’t know if you have been bitten or not. Antimalarial medication works by killing the malaria parasites during their development stage in the liver and red blood cells. You need to begin taking your antimalarial before you enter the risk area to give it time to establish in your system.

Malaria Prophylaxis

It must be remembered that no chemoprophylaxis regime provides 100% protection. Therefore it is essential to prevent mosquito bites as well as to comply with chemoprophylaxis. A possibility of malaria should be considered if a febrile illness develops after a week of entering a malarious area as well as up to over a year after visiting such an area, although it is more likely within the first 3 months of return.

Malaria Prophylaxis: A Comprehensive Review

Drug chemoprophylaxis has proved to be an effective preventive strategy in travellers to malaria- endemic areas [41], both for P. falciparum and non-falciparum malaria, despite it does not usually prevent the later relapses that can occur with P. vivax and P. ovale.

Monoclonal antibody could prevent malaria, study shows

Based on recent research, a “potential game changer” approach could offer a practical way to use monoclonal antibody therapies for malaria in Africa.

Prevention and Prophylaxis of Malaria in Older Travelers

Fixed-dose combination atovaquone/proguanil is well tolerated and convenient, making it a commonly prescribed agent for malaria prophylaxis. The effectiveness of atovaquone/proguanil against chloroquine-resistant and mefloquine-resistant P. falciparum also makes it an attractive option in areas where multidrug-resistant P. falciparum is endemic.

Ready to beat malaria: prospects for new interventions

A sobering thought is that a malaria parasite mutation causing drug resistance can arise during the course of infection in a single malaria patient, but it takes us more than 10 years from discovery to bring a new drug to the clinic - David Baker, LSHTM.

The Fight to End Malaria

Years ago, doctors treated the infected with quinine drugs, but today artemisinin-based combination treatments (ACTs) are accepted as the best treatments for malaria. Artemisinin, which China isolated in 1965 and earned scientist Tu Youyou the Nobel Prize, quickly reduces fevers and rapidly lowers blood-parasite levels. However, resistance to artemisinin emerged in Southeast Asia about 15 years ago. More recent studies have confirmed that malaria parasites resistant to ACTs have emerged in three disease-prone areas, Rwanda, Uganda and the Horn of Africa, with no immediate replacement available. There is also a vaccines on the market that shows efficacy against malaria, but not potent enough to bring down incidence the way the smallpox vaccine eradicated that virus in the 1960s and 1970s. Other vaccines are in the pipeline. Rising resistance to insecticide-treated nets remain a major concern in Africa, while malaria parasites are escaping detection from the most widely used diagnostic tests.

The past, present and future of anti-malarial medicines

With the recent emergence of resistance to current front-line artemisinin-based combination therapy, the need for the discovery of new anti-malarials that can act through novel mechanisms of action has been pushed firmly to the top of the development agenda.

What is the most effective and safe malaria prophylaxis during pregnancy?

Chloroquine and mefloquine have superior safety profiles in pregnancy, though all antimalarials are effective for prophylaxis. Antimalarials will decrease the severity of maternal malaria infection and malariaassociated anemia, while decreasing the incidence of low birth weight and perinatal death in women having their first or second baby (strength of recommendation.

What will a single-dose malaria drug mean for people in rural Brazil?

So, Brazil is trying something new: it is the first malaria-endemic country in the world to adopt tafenoquine – a medicine taken as a single dose – for treating P. vivax cases. When possible, primaquine will be replaced and the treatment will include chloroquine for three days and two pills of tafenoquine on the first day only. The “new” drug was discovered in 1978 at the US Walter Reed Army Institute of Research but developed over the past 15 years by GlaxoSmithKline (GSK) and the Medicines for Malaria Venture (MMV).

Which malaria tablets should I take?

With many different options available when it comes to antimalarial medication, it can be confusing working out which one is best for you.

Resources

Medicines for Malaria Venture

Our mission is to reduce the burden of malaria in disease-endemic countries by discovering, developing and facilitating delivery of new, effective and affordable antimalarial drugs.

Push Health

Malaria prophylaxis, sometimes referred to as malaria prevention medication, consists of specific medications that reduce the risk that one will contract malaria if exposed to it while traveling. Push Health can connect people in need of a malaria medication prescription with local medical providers who can prescribe malaria pills if it is safe and appropriate to do so.

CDC

No antimalarial drug is 100% protective and must be combined with the use of personal protective measures, (i.e., insect repellent, long sleeves, long pants, sleeping in a mosquito-free setting or using an insecticide-treated bednet).

StatPearls

Malarial chemoprophylaxis functions by targeting the liver schizont, blood schizont, or hypnozoite stages of the plasmodium life cycle. The three most commonly prescribed medications for chemoprophylaxis are atovaquone-proguanil, doxycycline, and mefloquine.